nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—CYP3A7—Vincristine—muscle cancer	0.0632	0.147	CbGbCtD
Aripiprazole—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0632	0.147	CbGbCtD
Aripiprazole—ABCB1—Dactinomycin—muscle cancer	0.0501	0.117	CbGbCtD
Aripiprazole—CYP3A5—Vincristine—muscle cancer	0.0474	0.11	CbGbCtD
Aripiprazole—CYP3A5—Etoposide—muscle cancer	0.0434	0.101	CbGbCtD
Aripiprazole—ABCB1—Vincristine—muscle cancer	0.0308	0.0718	CbGbCtD
Aripiprazole—ABCB1—Etoposide—muscle cancer	0.0283	0.0658	CbGbCtD
Aripiprazole—ABCB1—Doxorubicin—muscle cancer	0.0193	0.0449	CbGbCtD
Aripiprazole—ABCB1—Methotrexate—muscle cancer	0.0187	0.0435	CbGbCtD
Aripiprazole—CYP3A4—Vincristine—muscle cancer	0.0185	0.043	CbGbCtD
Aripiprazole—CYP2D6—Doxorubicin—muscle cancer	0.0182	0.0423	CbGbCtD
Aripiprazole—CYP3A4—Etoposide—muscle cancer	0.0169	0.0394	CbGbCtD
Aripiprazole—CHRM3—muscle of abdomen—muscle cancer	0.0121	0.104	CbGeAlD
Aripiprazole—CYP3A4—Doxorubicin—muscle cancer	0.0116	0.0269	CbGbCtD
Aripiprazole—HTR2A—hindlimb—muscle cancer	0.00367	0.0316	CbGeAlD
Aripiprazole—HTR2A—appendage—muscle cancer	0.00315	0.0271	CbGeAlD
Aripiprazole—H1F0—embryo—muscle cancer	0.00272	0.0234	CbGeAlD
Aripiprazole—DRD4—testis—muscle cancer	0.00261	0.0224	CbGeAlD
Aripiprazole—HTR1E—head—muscle cancer	0.00233	0.02	CbGeAlD
Aripiprazole—ADRA1B—renal system—muscle cancer	0.00218	0.0187	CbGeAlD
Aripiprazole—H1F0—smooth muscle tissue—muscle cancer	0.00214	0.0184	CbGeAlD
Aripiprazole—H1F0—renal system—muscle cancer	0.00206	0.0177	CbGeAlD
Aripiprazole—CHRM4—head—muscle cancer	0.00204	0.0176	CbGeAlD
Aripiprazole—CHRM4—testis—muscle cancer	0.00197	0.017	CbGeAlD
Aripiprazole—DRD3—head—muscle cancer	0.0019	0.0163	CbGeAlD
Aripiprazole—H1F0—cardiac atrium—muscle cancer	0.00184	0.0158	CbGeAlD
Aripiprazole—HTR6—head—muscle cancer	0.00183	0.0157	CbGeAlD
Aripiprazole—DRD5—head—muscle cancer	0.00178	0.0153	CbGeAlD
Aripiprazole—H1F0—tendon—muscle cancer	0.00161	0.0138	CbGeAlD
Aripiprazole—CHRM5—head—muscle cancer	0.0016	0.0137	CbGeAlD
Aripiprazole—H1F0—bone marrow—muscle cancer	0.00156	0.0134	CbGeAlD
Aripiprazole—HTR2B—smooth muscle tissue—muscle cancer	0.00154	0.0132	CbGeAlD
Aripiprazole—H1F0—vagina—muscle cancer	0.00149	0.0128	CbGeAlD
Aripiprazole—ADRA1B—head—muscle cancer	0.00146	0.0125	CbGeAlD
Aripiprazole—ADRB1—cardiac atrium—muscle cancer	0.00139	0.0119	CbGeAlD
Aripiprazole—CHRM3—smooth muscle tissue—muscle cancer	0.00139	0.0119	CbGeAlD
Aripiprazole—H1F0—head—muscle cancer	0.00138	0.0118	CbGeAlD
Aripiprazole—DRD1—head—muscle cancer	0.00136	0.0117	CbGeAlD
Aripiprazole—CHRM3—renal system—muscle cancer	0.00133	0.0115	CbGeAlD
Aripiprazole—H1F0—testis—muscle cancer	0.00133	0.0114	CbGeAlD
Aripiprazole—HTR1A—renal system—muscle cancer	0.00133	0.0114	CbGeAlD
Aripiprazole—HTR7—smooth muscle tissue—muscle cancer	0.00132	0.0113	CbGeAlD
Aripiprazole—HTR3A—head—muscle cancer	0.00131	0.0113	CbGeAlD
Aripiprazole—HTR7—renal system—muscle cancer	0.00127	0.0109	CbGeAlD
Aripiprazole—ADRA1A—renal system—muscle cancer	0.00123	0.0105	CbGeAlD
Aripiprazole—KCNH2—renal system—muscle cancer	0.00118	0.0102	CbGeAlD
Aripiprazole—ADRA2C—renal system—muscle cancer	0.00117	0.01	CbGeAlD
Aripiprazole—HTR2B—tendon—muscle cancer	0.00116	0.00995	CbGeAlD
Aripiprazole—HTR1B—head—muscle cancer	0.0011	0.00947	CbGeAlD
Aripiprazole—CHRM2—head—muscle cancer	0.0011	0.00942	CbGeAlD
Aripiprazole—HTR2B—vagina—muscle cancer	0.00107	0.00924	CbGeAlD
Aripiprazole—HTR1D—head—muscle cancer	0.00107	0.00917	CbGeAlD
Aripiprazole—KCNH2—cardiac atrium—muscle cancer	0.00106	0.00911	CbGeAlD
Aripiprazole—HTR2C—head—muscle cancer	0.00106	0.00908	CbGeAlD
Aripiprazole—HTR2A—embryo—muscle cancer	0.00105	0.009	CbGeAlD
Aripiprazole—ADRA2C—cardiac atrium—muscle cancer	0.00105	0.00899	CbGeAlD
Aripiprazole—ADRB1—head—muscle cancer	0.00104	0.00891	CbGeAlD
Aripiprazole—SLC6A4—head—muscle cancer	0.001	0.00861	CbGeAlD
Aripiprazole—CHRM1—head—muscle cancer	0.000998	0.00858	CbGeAlD
Aripiprazole—HTR2B—head—muscle cancer	0.000992	0.00853	CbGeAlD
Aripiprazole—HTR7—tendon—muscle cancer	0.000991	0.00852	CbGeAlD
Aripiprazole—HRH1—smooth muscle tissue—muscle cancer	0.000985	0.00847	CbGeAlD
Aripiprazole—CYP3A5—renal system—muscle cancer	0.000977	0.0084	CbGeAlD
Aripiprazole—ADRA2C—tendon—muscle cancer	0.000911	0.00783	CbGeAlD
Aripiprazole—KCNH2—bone marrow—muscle cancer	0.000895	0.00769	CbGeAlD
Aripiprazole—CHRM3—head—muscle cancer	0.000893	0.00768	CbGeAlD
Aripiprazole—HTR1A—head—muscle cancer	0.000889	0.00765	CbGeAlD
Aripiprazole—CHRM3—testis—muscle cancer	0.000862	0.00742	CbGeAlD
Aripiprazole—KCNH2—vagina—muscle cancer	0.000857	0.00737	CbGeAlD
Aripiprazole—HTR7—head—muscle cancer	0.00085	0.00731	CbGeAlD
Aripiprazole—ADRA2C—vagina—muscle cancer	0.000846	0.00727	CbGeAlD
Aripiprazole—ADRA2A—cardiac atrium—muscle cancer	0.000834	0.00717	CbGeAlD
Aripiprazole—HTR2A—smooth muscle tissue—muscle cancer	0.000823	0.00707	CbGeAlD
Aripiprazole—HTR7—testis—muscle cancer	0.000821	0.00706	CbGeAlD
Aripiprazole—ADRA1A—head—muscle cancer	0.00082	0.00705	CbGeAlD
Aripiprazole—DRD2—head—muscle cancer	0.000803	0.00691	CbGeAlD
Aripiprazole—HTR2A—renal system—muscle cancer	0.000792	0.00681	CbGeAlD
Aripiprazole—KCNH2—head—muscle cancer	0.000792	0.00681	CbGeAlD
Aripiprazole—ADRA2C—head—muscle cancer	0.000781	0.00672	CbGeAlD
Aripiprazole—DRD2—testis—muscle cancer	0.000776	0.00667	CbGeAlD
Aripiprazole—KCNH2—testis—muscle cancer	0.000765	0.00658	CbGeAlD
Aripiprazole—ADRA2C—testis—muscle cancer	0.000755	0.00649	CbGeAlD
Aripiprazole—HRH1—tendon—muscle cancer	0.00074	0.00636	CbGeAlD
Aripiprazole—CYP3A4—renal system—muscle cancer	0.000733	0.0063	CbGeAlD
Aripiprazole—ADRA2A—tendon—muscle cancer	0.000727	0.00625	CbGeAlD
Aripiprazole—CYP2D6—renal system—muscle cancer	0.000722	0.0062	CbGeAlD
Aripiprazole—CYP3A5—vagina—muscle cancer	0.000708	0.00608	CbGeAlD
Aripiprazole—HRH1—vagina—muscle cancer	0.000687	0.00591	CbGeAlD
Aripiprazole—ABCB1—embryo—muscle cancer	0.000686	0.0059	CbGeAlD
Aripiprazole—ADRA2A—vagina—muscle cancer	0.000675	0.0058	CbGeAlD
Aripiprazole—HRH1—head—muscle cancer	0.000634	0.00546	CbGeAlD
Aripiprazole—ADRA2A—head—muscle cancer	0.000623	0.00536	CbGeAlD
Aripiprazole—HTR2A—tendon—muscle cancer	0.000618	0.00532	CbGeAlD
Aripiprazole—HRH1—testis—muscle cancer	0.000613	0.00527	CbGeAlD
Aripiprazole—ADRA2A—testis—muscle cancer	0.000602	0.00518	CbGeAlD
Aripiprazole—HTR2A—vagina—muscle cancer	0.000574	0.00493	CbGeAlD
Aripiprazole—HTR2A—head—muscle cancer	0.00053	0.00456	CbGeAlD
Aripiprazole—ABCB1—renal system—muscle cancer	0.000519	0.00446	CbGeAlD
Aripiprazole—HTR2A—testis—muscle cancer	0.000512	0.0044	CbGeAlD
Aripiprazole—CYP2D6—head—muscle cancer	0.000483	0.00415	CbGeAlD
Aripiprazole—CYP2D6—testis—muscle cancer	0.000466	0.00401	CbGeAlD
Aripiprazole—ABCB1—bone marrow—muscle cancer	0.000392	0.00337	CbGeAlD
Aripiprazole—ABCB1—vagina—muscle cancer	0.000376	0.00323	CbGeAlD
Aripiprazole—ABCB1—head—muscle cancer	0.000347	0.00299	CbGeAlD
Aripiprazole—Liver function test abnormal—Doxorubicin—muscle cancer	0.000347	0.000779	CcSEcCtD
Aripiprazole—Skin disorder—Etoposide—muscle cancer	0.000346	0.000776	CcSEcCtD
Aripiprazole—Erectile dysfunction—Methotrexate—muscle cancer	0.000346	0.000775	CcSEcCtD
Aripiprazole—Dry skin—Doxorubicin—muscle cancer	0.000345	0.000773	CcSEcCtD
Aripiprazole—Hyperhidrosis—Etoposide—muscle cancer	0.000344	0.000773	CcSEcCtD
Aripiprazole—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000343	0.00077	CcSEcCtD
Aripiprazole—Abdominal pain upper—Doxorubicin—muscle cancer	0.000343	0.00077	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Methotrexate—muscle cancer	0.000343	0.000769	CcSEcCtD
Aripiprazole—Hypokalaemia—Doxorubicin—muscle cancer	0.000342	0.000768	CcSEcCtD
Aripiprazole—Breast disorder—Doxorubicin—muscle cancer	0.00034	0.000762	CcSEcCtD
Aripiprazole—Anorexia—Etoposide—muscle cancer	0.00034	0.000762	CcSEcCtD
Aripiprazole—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000339	0.00076	CcSEcCtD
Aripiprazole—Diarrhoea—Dactinomycin—muscle cancer	0.000337	0.000756	CcSEcCtD
Aripiprazole—Pneumonia—Methotrexate—muscle cancer	0.000337	0.000755	CcSEcCtD
Aripiprazole—Nasopharyngitis—Doxorubicin—muscle cancer	0.000336	0.000754	CcSEcCtD
Aripiprazole—ABCB1—testis—muscle cancer	0.000335	0.00288	CbGeAlD
Aripiprazole—Infestation NOS—Methotrexate—muscle cancer	0.000335	0.000751	CcSEcCtD
Aripiprazole—Infestation—Methotrexate—muscle cancer	0.000335	0.000751	CcSEcCtD
Aripiprazole—Depression—Methotrexate—muscle cancer	0.000334	0.000749	CcSEcCtD
Aripiprazole—Hypotension—Etoposide—muscle cancer	0.000333	0.000747	CcSEcCtD
Aripiprazole—Gastritis—Doxorubicin—muscle cancer	0.000333	0.000747	CcSEcCtD
Aripiprazole—Muscular weakness—Doxorubicin—muscle cancer	0.000332	0.000744	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000332	0.000744	CcSEcCtD
Aripiprazole—Renal failure—Methotrexate—muscle cancer	0.000329	0.000738	CcSEcCtD
Aripiprazole—Abdominal distension—Doxorubicin—muscle cancer	0.000327	0.000734	CcSEcCtD
Aripiprazole—Stomatitis—Methotrexate—muscle cancer	0.000326	0.000732	CcSEcCtD
Aripiprazole—Conjunctivitis—Methotrexate—muscle cancer	0.000325	0.00073	CcSEcCtD
Aripiprazole—Asthma—Doxorubicin—muscle cancer	0.000325	0.000729	CcSEcCtD
Aripiprazole—Dysphagia—Doxorubicin—muscle cancer	0.000325	0.000729	CcSEcCtD
Aripiprazole—Influenza—Doxorubicin—muscle cancer	0.000325	0.000729	CcSEcCtD
Aripiprazole—Hypersensitivity—Vincristine—muscle cancer	0.000324	0.000727	CcSEcCtD
Aripiprazole—Eosinophilia—Doxorubicin—muscle cancer	0.000322	0.000722	CcSEcCtD
Aripiprazole—Sweating—Methotrexate—muscle cancer	0.000321	0.00072	CcSEcCtD
Aripiprazole—Paraesthesia—Etoposide—muscle cancer	0.00032	0.000718	CcSEcCtD
Aripiprazole—Haematuria—Methotrexate—muscle cancer	0.000319	0.000716	CcSEcCtD
Aripiprazole—Pancreatitis—Doxorubicin—muscle cancer	0.000319	0.000715	CcSEcCtD
Aripiprazole—Dyspnoea—Etoposide—muscle cancer	0.000318	0.000713	CcSEcCtD
Aripiprazole—Somnolence—Etoposide—muscle cancer	0.000317	0.000711	CcSEcCtD
Aripiprazole—Angina pectoris—Doxorubicin—muscle cancer	0.000317	0.00071	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Methotrexate—muscle cancer	0.000316	0.00071	CcSEcCtD
Aripiprazole—Epistaxis—Methotrexate—muscle cancer	0.000316	0.000708	CcSEcCtD
Aripiprazole—Asthenia—Vincristine—muscle cancer	0.000316	0.000708	CcSEcCtD
Aripiprazole—Vomiting—Dactinomycin—muscle cancer	0.000313	0.000702	CcSEcCtD
Aripiprazole—Agranulocytosis—Methotrexate—muscle cancer	0.000312	0.000701	CcSEcCtD
Aripiprazole—Rash—Dactinomycin—muscle cancer	0.00031	0.000696	CcSEcCtD
Aripiprazole—Decreased appetite—Etoposide—muscle cancer	0.00031	0.000695	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Etoposide—muscle cancer	0.000308	0.00069	CcSEcCtD
Aripiprazole—Fatigue—Etoposide—muscle cancer	0.000307	0.000689	CcSEcCtD
Aripiprazole—Pain—Etoposide—muscle cancer	0.000305	0.000684	CcSEcCtD
Aripiprazole—Constipation—Etoposide—muscle cancer	0.000305	0.000684	CcSEcCtD
Aripiprazole—Dysuria—Doxorubicin—muscle cancer	0.000304	0.000682	CcSEcCtD
Aripiprazole—Neutropenia—Doxorubicin—muscle cancer	0.000304	0.000682	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000302	0.000678	CcSEcCtD
Aripiprazole—Haemoglobin—Methotrexate—muscle cancer	0.000302	0.000677	CcSEcCtD
Aripiprazole—Diarrhoea—Vincristine—muscle cancer	0.000301	0.000675	CcSEcCtD
Aripiprazole—Hepatitis—Methotrexate—muscle cancer	0.0003	0.000674	CcSEcCtD
Aripiprazole—Haemorrhage—Methotrexate—muscle cancer	0.0003	0.000674	CcSEcCtD
Aripiprazole—Pollakiuria—Doxorubicin—muscle cancer	0.0003	0.000673	CcSEcCtD
Aripiprazole—Pharyngitis—Methotrexate—muscle cancer	0.000298	0.000669	CcSEcCtD
Aripiprazole—Urinary tract disorder—Methotrexate—muscle cancer	0.000297	0.000666	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000297	0.000665	CcSEcCtD
Aripiprazole—Weight increased—Doxorubicin—muscle cancer	0.000296	0.000663	CcSEcCtD
Aripiprazole—Urethral disorder—Methotrexate—muscle cancer	0.000294	0.000661	CcSEcCtD
Aripiprazole—Weight decreased—Doxorubicin—muscle cancer	0.000294	0.00066	CcSEcCtD
Aripiprazole—Feeling abnormal—Etoposide—muscle cancer	0.000294	0.000659	CcSEcCtD
Aripiprazole—Hyperglycaemia—Doxorubicin—muscle cancer	0.000293	0.000658	CcSEcCtD
Aripiprazole—Nausea—Dactinomycin—muscle cancer	0.000292	0.000656	CcSEcCtD
Aripiprazole—Pneumonia—Doxorubicin—muscle cancer	0.000291	0.000654	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Etoposide—muscle cancer	0.000291	0.000654	CcSEcCtD
Aripiprazole—Dizziness—Vincristine—muscle cancer	0.000291	0.000653	CcSEcCtD
Aripiprazole—Infestation NOS—Doxorubicin—muscle cancer	0.00029	0.00065	CcSEcCtD
Aripiprazole—Infestation—Doxorubicin—muscle cancer	0.00029	0.00065	CcSEcCtD
Aripiprazole—Visual impairment—Methotrexate—muscle cancer	0.000289	0.000649	CcSEcCtD
Aripiprazole—Renal failure—Doxorubicin—muscle cancer	0.000285	0.000639	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000284	0.000637	CcSEcCtD
Aripiprazole—Urticaria—Etoposide—muscle cancer	0.000283	0.000635	CcSEcCtD
Aripiprazole—Stomatitis—Doxorubicin—muscle cancer	0.000282	0.000634	CcSEcCtD
Aripiprazole—Jaundice—Doxorubicin—muscle cancer	0.000282	0.000634	CcSEcCtD
Aripiprazole—Body temperature increased—Etoposide—muscle cancer	0.000282	0.000632	CcSEcCtD
Aripiprazole—Abdominal pain—Etoposide—muscle cancer	0.000282	0.000632	CcSEcCtD
Aripiprazole—Conjunctivitis—Doxorubicin—muscle cancer	0.000282	0.000632	CcSEcCtD
Aripiprazole—Urinary tract infection—Doxorubicin—muscle cancer	0.000282	0.000632	CcSEcCtD
Aripiprazole—Eye disorder—Methotrexate—muscle cancer	0.000281	0.00063	CcSEcCtD
Aripiprazole—Tinnitus—Methotrexate—muscle cancer	0.00028	0.000628	CcSEcCtD
Aripiprazole—Vomiting—Vincristine—muscle cancer	0.00028	0.000627	CcSEcCtD
Aripiprazole—Cardiac disorder—Methotrexate—muscle cancer	0.000279	0.000625	CcSEcCtD
Aripiprazole—Sweating—Doxorubicin—muscle cancer	0.000278	0.000623	CcSEcCtD
Aripiprazole—Rash—Vincristine—muscle cancer	0.000277	0.000622	CcSEcCtD
Aripiprazole—Dermatitis—Vincristine—muscle cancer	0.000277	0.000622	CcSEcCtD
Aripiprazole—Haematuria—Doxorubicin—muscle cancer	0.000276	0.00062	CcSEcCtD
Aripiprazole—Headache—Vincristine—muscle cancer	0.000276	0.000618	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000274	0.000615	CcSEcCtD
Aripiprazole—Epistaxis—Doxorubicin—muscle cancer	0.000273	0.000613	CcSEcCtD
Aripiprazole—Angiopathy—Methotrexate—muscle cancer	0.000273	0.000611	CcSEcCtD
Aripiprazole—Sinusitis—Doxorubicin—muscle cancer	0.000272	0.00061	CcSEcCtD
Aripiprazole—Immune system disorder—Methotrexate—muscle cancer	0.000271	0.000609	CcSEcCtD
Aripiprazole—Mediastinal disorder—Methotrexate—muscle cancer	0.000271	0.000607	CcSEcCtD
Aripiprazole—Agranulocytosis—Doxorubicin—muscle cancer	0.00027	0.000607	CcSEcCtD
Aripiprazole—Chills—Methotrexate—muscle cancer	0.00027	0.000605	CcSEcCtD
Aripiprazole—Alopecia—Methotrexate—muscle cancer	0.000265	0.000596	CcSEcCtD
Aripiprazole—Bradycardia—Doxorubicin—muscle cancer	0.000265	0.000594	CcSEcCtD
Aripiprazole—Mental disorder—Methotrexate—muscle cancer	0.000263	0.00059	CcSEcCtD
Aripiprazole—Hypersensitivity—Etoposide—muscle cancer	0.000263	0.000589	CcSEcCtD
Aripiprazole—Malnutrition—Methotrexate—muscle cancer	0.000261	0.000587	CcSEcCtD
Aripiprazole—Erythema—Methotrexate—muscle cancer	0.000261	0.000587	CcSEcCtD
Aripiprazole—Haemoglobin—Doxorubicin—muscle cancer	0.000261	0.000587	CcSEcCtD
Aripiprazole—Nausea—Vincristine—muscle cancer	0.000261	0.000586	CcSEcCtD
Aripiprazole—Rhinitis—Doxorubicin—muscle cancer	0.000261	0.000585	CcSEcCtD
Aripiprazole—Haemorrhage—Doxorubicin—muscle cancer	0.00026	0.000584	CcSEcCtD
Aripiprazole—Hepatitis—Doxorubicin—muscle cancer	0.00026	0.000584	CcSEcCtD
Aripiprazole—Hypoaesthesia—Doxorubicin—muscle cancer	0.000259	0.000581	CcSEcCtD
Aripiprazole—Pharyngitis—Doxorubicin—muscle cancer	0.000258	0.000579	CcSEcCtD
Aripiprazole—Urinary tract disorder—Doxorubicin—muscle cancer	0.000257	0.000576	CcSEcCtD
Aripiprazole—Oedema peripheral—Doxorubicin—muscle cancer	0.000256	0.000575	CcSEcCtD
Aripiprazole—Dysgeusia—Methotrexate—muscle cancer	0.000256	0.000574	CcSEcCtD
Aripiprazole—Asthenia—Etoposide—muscle cancer	0.000256	0.000574	CcSEcCtD
Aripiprazole—Connective tissue disorder—Doxorubicin—muscle cancer	0.000256	0.000573	CcSEcCtD
Aripiprazole—Urethral disorder—Doxorubicin—muscle cancer	0.000255	0.000572	CcSEcCtD
Aripiprazole—Back pain—Methotrexate—muscle cancer	0.000253	0.000567	CcSEcCtD
Aripiprazole—Pruritus—Etoposide—muscle cancer	0.000252	0.000566	CcSEcCtD
Aripiprazole—Visual impairment—Doxorubicin—muscle cancer	0.000251	0.000562	CcSEcCtD
Aripiprazole—Vision blurred—Methotrexate—muscle cancer	0.000246	0.000553	CcSEcCtD
Aripiprazole—Diarrhoea—Etoposide—muscle cancer	0.000244	0.000547	CcSEcCtD
Aripiprazole—Eye disorder—Doxorubicin—muscle cancer	0.000243	0.000545	CcSEcCtD
Aripiprazole—Ill-defined disorder—Methotrexate—muscle cancer	0.000243	0.000544	CcSEcCtD
Aripiprazole—Tinnitus—Doxorubicin—muscle cancer	0.000243	0.000544	CcSEcCtD
Aripiprazole—Anaemia—Methotrexate—muscle cancer	0.000242	0.000542	CcSEcCtD
Aripiprazole—Cardiac disorder—Doxorubicin—muscle cancer	0.000241	0.000542	CcSEcCtD
Aripiprazole—Flushing—Doxorubicin—muscle cancer	0.000241	0.000542	CcSEcCtD
Aripiprazole—Angiopathy—Doxorubicin—muscle cancer	0.000236	0.000529	CcSEcCtD
Aripiprazole—Malaise—Methotrexate—muscle cancer	0.000236	0.000529	CcSEcCtD
Aripiprazole—Dizziness—Etoposide—muscle cancer	0.000236	0.000529	CcSEcCtD
Aripiprazole—Immune system disorder—Doxorubicin—muscle cancer	0.000235	0.000527	CcSEcCtD
Aripiprazole—Vertigo—Methotrexate—muscle cancer	0.000235	0.000527	CcSEcCtD
Aripiprazole—Mediastinal disorder—Doxorubicin—muscle cancer	0.000234	0.000526	CcSEcCtD
Aripiprazole—Leukopenia—Methotrexate—muscle cancer	0.000234	0.000525	CcSEcCtD
Aripiprazole—Chills—Doxorubicin—muscle cancer	0.000233	0.000524	CcSEcCtD
Aripiprazole—Alopecia—Doxorubicin—muscle cancer	0.00023	0.000516	CcSEcCtD
Aripiprazole—Cough—Methotrexate—muscle cancer	0.000228	0.000512	CcSEcCtD
Aripiprazole—Mental disorder—Doxorubicin—muscle cancer	0.000228	0.000511	CcSEcCtD
Aripiprazole—Convulsion—Methotrexate—muscle cancer	0.000227	0.000508	CcSEcCtD
Aripiprazole—Vomiting—Etoposide—muscle cancer	0.000227	0.000508	CcSEcCtD
Aripiprazole—Malnutrition—Doxorubicin—muscle cancer	0.000226	0.000508	CcSEcCtD
Aripiprazole—Erythema—Doxorubicin—muscle cancer	0.000226	0.000508	CcSEcCtD
Aripiprazole—Rash—Etoposide—muscle cancer	0.000225	0.000504	CcSEcCtD
Aripiprazole—Dermatitis—Etoposide—muscle cancer	0.000224	0.000504	CcSEcCtD
Aripiprazole—Headache—Etoposide—muscle cancer	0.000223	0.000501	CcSEcCtD
Aripiprazole—Flatulence—Doxorubicin—muscle cancer	0.000223	0.000501	CcSEcCtD
Aripiprazole—Myalgia—Methotrexate—muscle cancer	0.000223	0.000499	CcSEcCtD
Aripiprazole—Chest pain—Methotrexate—muscle cancer	0.000223	0.000499	CcSEcCtD
Aripiprazole—Arthralgia—Methotrexate—muscle cancer	0.000223	0.000499	CcSEcCtD
Aripiprazole—Tension—Doxorubicin—muscle cancer	0.000222	0.000498	CcSEcCtD
Aripiprazole—Dysgeusia—Doxorubicin—muscle cancer	0.000222	0.000497	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000221	0.000496	CcSEcCtD
Aripiprazole—Discomfort—Methotrexate—muscle cancer	0.00022	0.000493	CcSEcCtD
Aripiprazole—Nervousness—Doxorubicin—muscle cancer	0.00022	0.000493	CcSEcCtD
Aripiprazole—Back pain—Doxorubicin—muscle cancer	0.000219	0.000491	CcSEcCtD
Aripiprazole—Muscle spasms—Doxorubicin—muscle cancer	0.000218	0.000488	CcSEcCtD
Aripiprazole—Confusional state—Methotrexate—muscle cancer	0.000215	0.000483	CcSEcCtD
Aripiprazole—Anaphylactic shock—Methotrexate—muscle cancer	0.000213	0.000479	CcSEcCtD
Aripiprazole—Vision blurred—Doxorubicin—muscle cancer	0.000213	0.000479	CcSEcCtD
Aripiprazole—Infection—Methotrexate—muscle cancer	0.000212	0.000476	CcSEcCtD
Aripiprazole—Nausea—Etoposide—muscle cancer	0.000212	0.000475	CcSEcCtD
Aripiprazole—Ill-defined disorder—Doxorubicin—muscle cancer	0.00021	0.000471	CcSEcCtD
Aripiprazole—Nervous system disorder—Methotrexate—muscle cancer	0.000209	0.00047	CcSEcCtD
Aripiprazole—Anaemia—Doxorubicin—muscle cancer	0.000209	0.00047	CcSEcCtD
Aripiprazole—Thrombocytopenia—Methotrexate—muscle cancer	0.000209	0.000469	CcSEcCtD
Aripiprazole—Agitation—Doxorubicin—muscle cancer	0.000208	0.000467	CcSEcCtD
Aripiprazole—Skin disorder—Methotrexate—muscle cancer	0.000207	0.000465	CcSEcCtD
Aripiprazole—Hyperhidrosis—Methotrexate—muscle cancer	0.000206	0.000463	CcSEcCtD
Aripiprazole—Malaise—Doxorubicin—muscle cancer	0.000204	0.000458	CcSEcCtD
Aripiprazole—Vertigo—Doxorubicin—muscle cancer	0.000203	0.000456	CcSEcCtD
Aripiprazole—Anorexia—Methotrexate—muscle cancer	0.000203	0.000456	CcSEcCtD
Aripiprazole—Syncope—Doxorubicin—muscle cancer	0.000203	0.000456	CcSEcCtD
Aripiprazole—Leukopenia—Doxorubicin—muscle cancer	0.000203	0.000455	CcSEcCtD
Aripiprazole—Palpitations—Doxorubicin—muscle cancer	0.0002	0.000449	CcSEcCtD
Aripiprazole—Hypotension—Methotrexate—muscle cancer	0.000199	0.000447	CcSEcCtD
Aripiprazole—Loss of consciousness—Doxorubicin—muscle cancer	0.000199	0.000446	CcSEcCtD
Aripiprazole—Cough—Doxorubicin—muscle cancer	0.000198	0.000443	CcSEcCtD
Aripiprazole—Convulsion—Doxorubicin—muscle cancer	0.000196	0.00044	CcSEcCtD
Aripiprazole—Hypertension—Doxorubicin—muscle cancer	0.000195	0.000439	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000194	0.000436	CcSEcCtD
Aripiprazole—Insomnia—Methotrexate—muscle cancer	0.000193	0.000433	CcSEcCtD
Aripiprazole—Chest pain—Doxorubicin—muscle cancer	0.000193	0.000432	CcSEcCtD
Aripiprazole—Arthralgia—Doxorubicin—muscle cancer	0.000193	0.000432	CcSEcCtD
Aripiprazole—Myalgia—Doxorubicin—muscle cancer	0.000193	0.000432	CcSEcCtD
Aripiprazole—Anxiety—Doxorubicin—muscle cancer	0.000192	0.000431	CcSEcCtD
Aripiprazole—Paraesthesia—Methotrexate—muscle cancer	0.000192	0.00043	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000191	0.000429	CcSEcCtD
Aripiprazole—Discomfort—Doxorubicin—muscle cancer	0.00019	0.000427	CcSEcCtD
Aripiprazole—Dyspnoea—Methotrexate—muscle cancer	0.00019	0.000427	CcSEcCtD
Aripiprazole—Somnolence—Methotrexate—muscle cancer	0.00019	0.000426	CcSEcCtD
Aripiprazole—Dry mouth—Doxorubicin—muscle cancer	0.000189	0.000423	CcSEcCtD
Aripiprazole—Dyspepsia—Methotrexate—muscle cancer	0.000188	0.000421	CcSEcCtD
Aripiprazole—Confusional state—Doxorubicin—muscle cancer	0.000186	0.000418	CcSEcCtD
Aripiprazole—Decreased appetite—Methotrexate—muscle cancer	0.000186	0.000416	CcSEcCtD
Aripiprazole—Oedema—Doxorubicin—muscle cancer	0.000185	0.000415	CcSEcCtD
Aripiprazole—Anaphylactic shock—Doxorubicin—muscle cancer	0.000185	0.000415	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000184	0.000413	CcSEcCtD
Aripiprazole—Fatigue—Methotrexate—muscle cancer	0.000184	0.000413	CcSEcCtD
Aripiprazole—Infection—Doxorubicin—muscle cancer	0.000184	0.000412	CcSEcCtD
Aripiprazole—Pain—Methotrexate—muscle cancer	0.000182	0.000409	CcSEcCtD
Aripiprazole—Shock—Doxorubicin—muscle cancer	0.000182	0.000408	CcSEcCtD
Aripiprazole—Nervous system disorder—Doxorubicin—muscle cancer	0.000181	0.000407	CcSEcCtD
Aripiprazole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000181	0.000406	CcSEcCtD
Aripiprazole—Tachycardia—Doxorubicin—muscle cancer	0.00018	0.000405	CcSEcCtD
Aripiprazole—Skin disorder—Doxorubicin—muscle cancer	0.000179	0.000403	CcSEcCtD
Aripiprazole—Hyperhidrosis—Doxorubicin—muscle cancer	0.000179	0.000401	CcSEcCtD
Aripiprazole—Anorexia—Doxorubicin—muscle cancer	0.000176	0.000395	CcSEcCtD
Aripiprazole—Feeling abnormal—Methotrexate—muscle cancer	0.000176	0.000395	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Methotrexate—muscle cancer	0.000175	0.000392	CcSEcCtD
Aripiprazole—Hypotension—Doxorubicin—muscle cancer	0.000173	0.000387	CcSEcCtD
Aripiprazole—Urticaria—Methotrexate—muscle cancer	0.00017	0.00038	CcSEcCtD
Aripiprazole—Body temperature increased—Methotrexate—muscle cancer	0.000169	0.000378	CcSEcCtD
Aripiprazole—Abdominal pain—Methotrexate—muscle cancer	0.000169	0.000378	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000168	0.000378	CcSEcCtD
Aripiprazole—Insomnia—Doxorubicin—muscle cancer	0.000167	0.000375	CcSEcCtD
Aripiprazole—Paraesthesia—Doxorubicin—muscle cancer	0.000166	0.000372	CcSEcCtD
Aripiprazole—Dyspnoea—Doxorubicin—muscle cancer	0.000165	0.00037	CcSEcCtD
Aripiprazole—Somnolence—Doxorubicin—muscle cancer	0.000164	0.000369	CcSEcCtD
Aripiprazole—Dyspepsia—Doxorubicin—muscle cancer	0.000163	0.000365	CcSEcCtD
Aripiprazole—Decreased appetite—Doxorubicin—muscle cancer	0.000161	0.00036	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00016	0.000358	CcSEcCtD
Aripiprazole—Fatigue—Doxorubicin—muscle cancer	0.000159	0.000357	CcSEcCtD
Aripiprazole—Pain—Doxorubicin—muscle cancer	0.000158	0.000355	CcSEcCtD
Aripiprazole—Constipation—Doxorubicin—muscle cancer	0.000158	0.000355	CcSEcCtD
Aripiprazole—Hypersensitivity—Methotrexate—muscle cancer	0.000157	0.000353	CcSEcCtD
Aripiprazole—Asthenia—Methotrexate—muscle cancer	0.000153	0.000344	CcSEcCtD
Aripiprazole—Feeling abnormal—Doxorubicin—muscle cancer	0.000152	0.000342	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000151	0.000339	CcSEcCtD
Aripiprazole—Pruritus—Methotrexate—muscle cancer	0.000151	0.000339	CcSEcCtD
Aripiprazole—Urticaria—Doxorubicin—muscle cancer	0.000147	0.000329	CcSEcCtD
Aripiprazole—Abdominal pain—Doxorubicin—muscle cancer	0.000146	0.000328	CcSEcCtD
Aripiprazole—Body temperature increased—Doxorubicin—muscle cancer	0.000146	0.000328	CcSEcCtD
Aripiprazole—Diarrhoea—Methotrexate—muscle cancer	0.000146	0.000328	CcSEcCtD
Aripiprazole—Dizziness—Methotrexate—muscle cancer	0.000141	0.000317	CcSEcCtD
Aripiprazole—Hypersensitivity—Doxorubicin—muscle cancer	0.000136	0.000305	CcSEcCtD
Aripiprazole—Vomiting—Methotrexate—muscle cancer	0.000136	0.000304	CcSEcCtD
Aripiprazole—Rash—Methotrexate—muscle cancer	0.000135	0.000302	CcSEcCtD
Aripiprazole—Dermatitis—Methotrexate—muscle cancer	0.000134	0.000302	CcSEcCtD
Aripiprazole—Headache—Methotrexate—muscle cancer	0.000134	0.0003	CcSEcCtD
Aripiprazole—Asthenia—Doxorubicin—muscle cancer	0.000133	0.000297	CcSEcCtD
Aripiprazole—Pruritus—Doxorubicin—muscle cancer	0.000131	0.000293	CcSEcCtD
Aripiprazole—Nausea—Methotrexate—muscle cancer	0.000127	0.000284	CcSEcCtD
Aripiprazole—Diarrhoea—Doxorubicin—muscle cancer	0.000126	0.000284	CcSEcCtD
Aripiprazole—Dizziness—Doxorubicin—muscle cancer	0.000122	0.000274	CcSEcCtD
Aripiprazole—Vomiting—Doxorubicin—muscle cancer	0.000117	0.000264	CcSEcCtD
Aripiprazole—Rash—Doxorubicin—muscle cancer	0.000117	0.000261	CcSEcCtD
Aripiprazole—Dermatitis—Doxorubicin—muscle cancer	0.000116	0.000261	CcSEcCtD
Aripiprazole—Headache—Doxorubicin—muscle cancer	0.000116	0.00026	CcSEcCtD
Aripiprazole—Nausea—Doxorubicin—muscle cancer	0.00011	0.000246	CcSEcCtD
Aripiprazole—DRD5—Signaling Pathways—IGF2—muscle cancer	6.67e-06	0.00079	CbGpPWpGaD
Aripiprazole—DRD2—Circadian rythm related genes—TP53—muscle cancer	6.55e-06	0.000775	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—MED12—muscle cancer	6.55e-06	0.000775	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—PTCH1—muscle cancer	6.42e-06	0.000761	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—FOXO4—muscle cancer	6.42e-06	0.00076	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—FOXO4—muscle cancer	6.41e-06	0.000759	CbGpPWpGaD
Aripiprazole—CHRM1—Circadian rythm related genes—TP53—muscle cancer	6.41e-06	0.000759	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—FOXO4—muscle cancer	6.37e-06	0.000754	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—PTCH1—muscle cancer	6.34e-06	0.000751	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—CNR1—muscle cancer	6.3e-06	0.000746	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—CNR1—muscle cancer	6.29e-06	0.000745	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—CNR1—muscle cancer	6.25e-06	0.00074	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—FOXO4—muscle cancer	6.23e-06	0.000738	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—CNR1—muscle cancer	6.2e-06	0.000735	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—FOXO1—muscle cancer	6.14e-06	0.000727	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—FOXO4—muscle cancer	6.13e-06	0.000727	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—CNR1—muscle cancer	6.12e-06	0.000725	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—FOXO4—muscle cancer	6.05e-06	0.000717	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—CNR1—muscle cancer	6.02e-06	0.000713	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—MED12—muscle cancer	6.01e-06	0.000711	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—ENO2—muscle cancer	5.97e-06	0.000707	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CNR1—muscle cancer	5.94e-06	0.000704	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—FOXO4—muscle cancer	5.86e-06	0.000694	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—FOXO4—muscle cancer	5.8e-06	0.000687	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—PTCH1—muscle cancer	5.77e-06	0.000684	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CNR1—muscle cancer	5.75e-06	0.000681	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—PTCH1—muscle cancer	5.72e-06	0.000678	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CNR1—muscle cancer	5.69e-06	0.000674	CbGpPWpGaD
Aripiprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	5.59e-06	0.000662	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—FOXO4—muscle cancer	5.52e-06	0.000654	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—PTCH1—muscle cancer	5.52e-06	0.000654	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—MED12—muscle cancer	5.5e-06	0.000652	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—PTCH1—muscle cancer	5.49e-06	0.000651	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—ENO2—muscle cancer	5.48e-06	0.000649	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—FOXO4—muscle cancer	5.45e-06	0.000645	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CNR1—muscle cancer	5.42e-06	0.000642	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CNR1—muscle cancer	5.35e-06	0.000634	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—PTCH1—muscle cancer	5.34e-06	0.000633	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—KIT—muscle cancer	5.29e-06	0.000626	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—PTCH1—muscle cancer	5.26e-06	0.000623	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IGF2—muscle cancer	5.15e-06	0.00061	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IGF2—muscle cancer	5.14e-06	0.000609	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IGF2—muscle cancer	5.11e-06	0.000605	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ENO2—muscle cancer	5.02e-06	0.000594	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IGF2—muscle cancer	5e-06	0.000593	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—FOXO4—muscle cancer	4.97e-06	0.000588	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IGF2—muscle cancer	4.92e-06	0.000583	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—FOXO4—muscle cancer	4.92e-06	0.000583	CbGpPWpGaD
Aripiprazole—ADRA2B—Hemostasis—VEGFA—muscle cancer	4.88e-06	0.000579	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CNR1—muscle cancer	4.87e-06	0.000577	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IGF2—muscle cancer	4.86e-06	0.000575	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—PTCH1—muscle cancer	4.85e-06	0.000574	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CNR1—muscle cancer	4.83e-06	0.000572	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—PTCH1—muscle cancer	4.77e-06	0.000565	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—PTCH1—muscle cancer	4.76e-06	0.000564	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—FOXO4—muscle cancer	4.75e-06	0.000563	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—PTCH1—muscle cancer	4.75e-06	0.000562	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—FOXO1—muscle cancer	4.74e-06	0.000561	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—FOXO1—muscle cancer	4.73e-06	0.000561	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—PTCH1—muscle cancer	4.73e-06	0.00056	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—FOXO4—muscle cancer	4.72e-06	0.00056	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—FOXO1—muscle cancer	4.7e-06	0.000557	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IGF2—muscle cancer	4.7e-06	0.000557	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—PTCH1—muscle cancer	4.68e-06	0.000555	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—KIT—muscle cancer	4.68e-06	0.000554	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—PTCH1—muscle cancer	4.67e-06	0.000553	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CNR1—muscle cancer	4.66e-06	0.000552	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IGF2—muscle cancer	4.65e-06	0.000551	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CNR1—muscle cancer	4.64e-06	0.000549	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—FOXO1—muscle cancer	4.6e-06	0.000545	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—FOXO4—muscle cancer	4.6e-06	0.000544	CbGpPWpGaD
Aripiprazole—ADRA2C—Hemostasis—VEGFA—muscle cancer	4.56e-06	0.00054	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—FOXO1—muscle cancer	4.53e-06	0.000537	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—FH—muscle cancer	4.53e-06	0.000536	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—FOXO4—muscle cancer	4.52e-06	0.000536	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CNR1—muscle cancer	4.51e-06	0.000534	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—FOXO1—muscle cancer	4.47e-06	0.000529	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CNR1—muscle cancer	4.44e-06	0.000526	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IGF2—muscle cancer	4.43e-06	0.000525	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IGF2—muscle cancer	4.37e-06	0.000518	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—PTCH1—muscle cancer	4.34e-06	0.000514	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—FOXO1—muscle cancer	4.33e-06	0.000512	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—FOXO1—muscle cancer	4.28e-06	0.000507	CbGpPWpGaD
Aripiprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	4.22e-06	0.0005	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—FOXO4—muscle cancer	4.17e-06	0.000494	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—MDM2—muscle cancer	4.16e-06	0.000493	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—MED12—muscle cancer	4.15e-06	0.000492	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—FOXO4—muscle cancer	4.1e-06	0.000486	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—FOXO4—muscle cancer	4.09e-06	0.000485	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CNR1—muscle cancer	4.09e-06	0.000485	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—FOXO4—muscle cancer	4.08e-06	0.000483	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—FOXO1—muscle cancer	4.08e-06	0.000483	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—FOXO4—muscle cancer	4.07e-06	0.000482	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—FOXO4—muscle cancer	4.03e-06	0.000477	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CNR1—muscle cancer	4.03e-06	0.000477	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—FOXO1—muscle cancer	4.02e-06	0.000477	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CNR1—muscle cancer	4.02e-06	0.000476	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—FOXO4—muscle cancer	4.02e-06	0.000476	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CNR1—muscle cancer	4.01e-06	0.000474	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CNR1—muscle cancer	3.99e-06	0.000473	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IGF2—muscle cancer	3.98e-06	0.000472	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CNR1—muscle cancer	3.95e-06	0.000468	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IGF2—muscle cancer	3.95e-06	0.000468	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CNR1—muscle cancer	3.94e-06	0.000467	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—MED12—muscle cancer	3.91e-06	0.000464	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IGF2—muscle cancer	3.81e-06	0.000451	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IGF2—muscle cancer	3.79e-06	0.000449	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ENO2—muscle cancer	3.79e-06	0.000449	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—FOXO4—muscle cancer	3.73e-06	0.000442	CbGpPWpGaD
Aripiprazole—ADRA2A—Hemostasis—VEGFA—muscle cancer	3.71e-06	0.000439	CbGpPWpGaD
Aripiprazole—ADRA2B—Hemostasis—TP53—muscle cancer	3.69e-06	0.000437	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IGF2—muscle cancer	3.69e-06	0.000437	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—MDM2—muscle cancer	3.68e-06	0.000436	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—FOXO1—muscle cancer	3.67e-06	0.000434	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CNR1—muscle cancer	3.66e-06	0.000434	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—FOXO1—muscle cancer	3.63e-06	0.00043	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IGF2—muscle cancer	3.63e-06	0.00043	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—KIT—muscle cancer	3.61e-06	0.000428	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—KIT—muscle cancer	3.61e-06	0.000427	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—KIT—muscle cancer	3.58e-06	0.000424	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ENO2—muscle cancer	3.57e-06	0.000423	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—KIT—muscle cancer	3.51e-06	0.000416	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—FOXO1—muscle cancer	3.51e-06	0.000415	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—FOXO1—muscle cancer	3.49e-06	0.000413	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—KIT—muscle cancer	3.45e-06	0.000409	CbGpPWpGaD
Aripiprazole—ADRA2C—Hemostasis—TP53—muscle cancer	3.45e-06	0.000408	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—KIT—muscle cancer	3.41e-06	0.000403	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—FOXO1—muscle cancer	3.39e-06	0.000402	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IGF2—muscle cancer	3.35e-06	0.000396	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—FOXO1—muscle cancer	3.34e-06	0.000396	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—KIT—muscle cancer	3.3e-06	0.00039	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IGF2—muscle cancer	3.29e-06	0.00039	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IGF2—muscle cancer	3.29e-06	0.000389	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IGF2—muscle cancer	3.27e-06	0.000388	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IGF2—muscle cancer	3.26e-06	0.000387	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—KIT—muscle cancer	3.26e-06	0.000386	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IGF2—muscle cancer	3.23e-06	0.000383	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IGF2—muscle cancer	3.22e-06	0.000382	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—VEGFA—muscle cancer	3.16e-06	0.000374	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—KIT—muscle cancer	3.11e-06	0.000368	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—FOXO1—muscle cancer	3.08e-06	0.000365	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—KIT—muscle cancer	3.07e-06	0.000363	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—FOXO1—muscle cancer	3.03e-06	0.000359	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—FOXO1—muscle cancer	3.02e-06	0.000358	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—FOXO1—muscle cancer	3.01e-06	0.000357	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—FOXO1—muscle cancer	3e-06	0.000356	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IGF2—muscle cancer	3e-06	0.000355	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—FOXO1—muscle cancer	2.98e-06	0.000352	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—FOXO1—muscle cancer	2.97e-06	0.000351	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MDM2—muscle cancer	2.84e-06	0.000337	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MDM2—muscle cancer	2.84e-06	0.000336	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MDM2—muscle cancer	2.82e-06	0.000334	CbGpPWpGaD
Aripiprazole—ADRA2A—Hemostasis—TP53—muscle cancer	2.8e-06	0.000332	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—VEGFA—muscle cancer	2.8e-06	0.000331	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—KIT—muscle cancer	2.79e-06	0.000331	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—KIT—muscle cancer	2.77e-06	0.000328	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MDM2—muscle cancer	2.76e-06	0.000327	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—FOXO1—muscle cancer	2.76e-06	0.000327	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MDM2—muscle cancer	2.72e-06	0.000322	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MDM2—muscle cancer	2.68e-06	0.000318	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—KIT—muscle cancer	2.67e-06	0.000317	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—KIT—muscle cancer	2.66e-06	0.000315	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MDM2—muscle cancer	2.6e-06	0.000307	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—KIT—muscle cancer	2.59e-06	0.000306	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MDM2—muscle cancer	2.57e-06	0.000304	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MED12—muscle cancer	2.56e-06	0.000303	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—KIT—muscle cancer	2.55e-06	0.000301	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MDM2—muscle cancer	2.45e-06	0.00029	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PTGS2—muscle cancer	2.42e-06	0.000286	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MDM2—muscle cancer	2.42e-06	0.000286	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—TP53—muscle cancer	2.39e-06	0.000283	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PTGS2—muscle cancer	2.35e-06	0.000278	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—KIT—muscle cancer	2.35e-06	0.000278	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ENO2—muscle cancer	2.33e-06	0.000276	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—KIT—muscle cancer	2.31e-06	0.000273	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—KIT—muscle cancer	2.3e-06	0.000273	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—KIT—muscle cancer	2.3e-06	0.000272	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—KIT—muscle cancer	2.29e-06	0.000271	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—KIT—muscle cancer	2.27e-06	0.000269	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—KIT—muscle cancer	2.26e-06	0.000268	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MDM2—muscle cancer	2.2e-06	0.000261	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MDM2—muscle cancer	2.18e-06	0.000258	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—VEGFA—muscle cancer	2.16e-06	0.000256	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—VEGFA—muscle cancer	2.16e-06	0.000255	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—VEGFA—muscle cancer	2.14e-06	0.000254	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—TP53—muscle cancer	2.11e-06	0.00025	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MDM2—muscle cancer	2.1e-06	0.000249	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—KIT—muscle cancer	2.1e-06	0.000249	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—VEGFA—muscle cancer	2.1e-06	0.000249	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MDM2—muscle cancer	2.09e-06	0.000248	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PTGS2—muscle cancer	2.08e-06	0.000246	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—VEGFA—muscle cancer	2.06e-06	0.000245	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—VEGFA—muscle cancer	2.04e-06	0.000241	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MDM2—muscle cancer	2.04e-06	0.000241	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MDM2—muscle cancer	2e-06	0.000237	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—VEGFA—muscle cancer	1.97e-06	0.000233	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—VEGFA—muscle cancer	1.95e-06	0.000231	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PTGS2—muscle cancer	1.91e-06	0.000226	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—VEGFA—muscle cancer	1.86e-06	0.00022	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MDM2—muscle cancer	1.85e-06	0.000219	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—VEGFA—muscle cancer	1.83e-06	0.000217	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MDM2—muscle cancer	1.82e-06	0.000215	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MDM2—muscle cancer	1.81e-06	0.000215	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MDM2—muscle cancer	1.81e-06	0.000214	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MDM2—muscle cancer	1.8e-06	0.000214	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MDM2—muscle cancer	1.79e-06	0.000211	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MDM2—muscle cancer	1.78e-06	0.000211	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—muscle cancer	1.75e-06	0.000207	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—muscle cancer	1.67e-06	0.000198	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—muscle cancer	1.66e-06	0.000196	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MDM2—muscle cancer	1.65e-06	0.000196	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TP53—muscle cancer	1.63e-06	0.000193	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TP53—muscle cancer	1.63e-06	0.000193	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TP53—muscle cancer	1.62e-06	0.000192	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—muscle cancer	1.6e-06	0.000189	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—muscle cancer	1.59e-06	0.000188	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—muscle cancer	1.59e-06	0.000188	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—muscle cancer	1.56e-06	0.000185	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—muscle cancer	1.55e-06	0.000183	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—muscle cancer	1.54e-06	0.000182	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—muscle cancer	1.52e-06	0.00018	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—muscle cancer	1.49e-06	0.000176	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—muscle cancer	1.47e-06	0.000175	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—muscle cancer	1.4e-06	0.000166	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—muscle cancer	1.4e-06	0.000166	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—muscle cancer	1.39e-06	0.000164	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—muscle cancer	1.38e-06	0.000164	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—muscle cancer	1.38e-06	0.000163	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—muscle cancer	1.37e-06	0.000163	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—muscle cancer	1.37e-06	0.000162	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—muscle cancer	1.36e-06	0.000161	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—muscle cancer	1.35e-06	0.00016	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—muscle cancer	1.32e-06	0.000156	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—muscle cancer	1.26e-06	0.00015	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—muscle cancer	1.26e-06	0.000149	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—muscle cancer	1.25e-06	0.000148	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—muscle cancer	1.24e-06	0.000147	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—muscle cancer	1.21e-06	0.000143	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—muscle cancer	1.2e-06	0.000142	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—muscle cancer	1.17e-06	0.000138	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—muscle cancer	1.15e-06	0.000136	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—muscle cancer	1.06e-06	0.000126	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—muscle cancer	1.04e-06	0.000124	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—muscle cancer	1.04e-06	0.000123	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—muscle cancer	1.04e-06	0.000123	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—muscle cancer	1.03e-06	0.000123	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—muscle cancer	1.02e-06	0.000121	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—muscle cancer	1.02e-06	0.000121	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—muscle cancer	9.49e-07	0.000112	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—muscle cancer	8.13e-07	9.63e-05	CbGpPWpGaD
